Nokia Corp vs Teladoc Health Inc — how do they compare? Nokia Corp trades at $10.36 (market cap $56.99B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: Nokia Corp is far larger — about 56.4× Teladoc Health Inc's market cap, and Nokia Corp pays a 1.61% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nokia Corp for 66 Days and Teladoc Health Inc for 39 Days on average.
| NOK | TDOC | |
|---|---|---|
Market Cap | $56.99B | $1.01B |
Volume | 69,968,204 | 4,668,477 |
Sector | Technology | Health |
52-Week High | $16.83 | $9.72 |
52-Week Low | $5.25 | $4.47 |
Typical Hold Time | 66 Days | 39 Days |
Enterprise Value | $55.01B | $1.27B |
Dividend Yield | 1.61% | — |
Signals from Pluang's Aura AI — not financial advice
Nokia (NOK) trades at $10.14, down 4.52% over 24 hours, with a bearish technical signal. The stock shows mixed earnings, beating estimates in Q4 2025 and Q2 2026 but missing in Q1 2026. Revenue has stabilized around $20B annually, with a net income margin of 3.47% in 2025. Analyst consensus is bullish, with a $17.50 price target, supported by recent partnerships in AI and satellite communications.
The outlook is cautiously optimistic, driven by AI infrastructure demand and strategic alliances, but risks include competitive pressures and volatile cash flows. Upside potential exists if execution on growth initiatives improves profitability, while downside risks stem from macroeconomic headwinds and execution missteps.
TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.
The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →